BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 15143948)

  • 1. [Clinical use of erythropoietin].
    Franchini M; Gandini G; Lippi G; De Gironcoli M; Cantini M; Aprili G
    Recenti Prog Med; 2004 Mar; 95(3):129-36; quiz 185. PubMed ID: 15143948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Human recombinant erythropoietin therapy].
    Donato H; Ferro H
    Medicina (B Aires); 2006; 66(1):51-69. PubMed ID: 16555732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietin therapy for anemia of prematurity.
    Merchant RH; Sonigara S; Sanghvi KP
    Indian Pediatr; 1996 Apr; 33(4):323-6. PubMed ID: 8772909
    [No Abstract]   [Full Text] [Related]  

  • 4. Is there a role for erythropoietin in neonatal medicine?
    Mainie P
    Early Hum Dev; 2008 Aug; 84(8):525-32. PubMed ID: 18653293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin and chronic lymphocytic leukemia.
    Mauro FR; Gentile M; Foa R
    Rev Clin Exp Hematol; 2002; Suppl 1():21-31. PubMed ID: 12735212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiologic basis for the pharmacologic use of recombinant human erythropoietin in surgery and cancer treatment.
    Adamson JW; Spivak JL
    Surgery; 1994 Jan; 115(1):7-15. PubMed ID: 8284765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin and its use in renal failure.
    Sulková S; Krajhanzl A
    EDTNA ERCA J; 1996; 22(1):suppl 1-7; quiz 8. PubMed ID: 10723310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant erythropoietin in anemia of prematurity: five years later.
    Shannon K
    Pediatrics; 1993 Oct; 92(4):614-7. PubMed ID: 8414840
    [No Abstract]   [Full Text] [Related]  

  • 9. Recombinant erythropoietin for the anemia of prematurity: still a promise, not a panacea.
    Strauss RG
    J Pediatr; 1997 Nov; 131(5):653-5. PubMed ID: 9403639
    [No Abstract]   [Full Text] [Related]  

  • 10. Autologous blood donation with recombinant human erythropoietin in cardiac surgery: the Japanese experience.
    Baron JF
    Semin Hematol; 1996 Apr; 33(2 Suppl 2):64-7; discussion 68. PubMed ID: 8723586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orally administrated Juzen-taiho-to/TJ-48 ameliorates erythropoietin (rHuEPO)-resistant anemia in patients on hemodialysis.
    Nakamoto H; Mimura T; Honda N
    Hemodial Int; 2008 Oct; 12 Suppl 2():S9-S14. PubMed ID: 18837771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonhematologic complications of erythropoietin therapy.
    Zhu X; Perazella MA
    Semin Dial; 2006; 19(4):279-84. PubMed ID: 16893404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Target hemoglobin level for EPO therapy in CKD.
    Parfrey PS
    Am J Kidney Dis; 2006 Jan; 47(1):171-3. PubMed ID: 16377399
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of human recombinant erythropoietin in children with cancer].
    Guyot D; Margueritte G
    Arch Pediatr; 2005 Sep; 12(9):1376-82. PubMed ID: 16084072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of erythropoietin in the treatment of patients with malignancies: methods and preliminary results of a Cochrane review.
    Bohlius JF; Langensiepen S; Engert A; Schwarzer G; Bennett CL
    Best Pract Res Clin Haematol; 2005; 18(3):449-54. PubMed ID: 15792919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternatives to blood product transfusion in the critically ill: erythropoietin.
    Stubbs JR
    Crit Care Med; 2006 May; 34(5 Suppl):S160-9. PubMed ID: 16617261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NCCN: New applications for erythropoietin.
    Demetri GD
    Cancer Control; 2001; 8(6 Suppl 2):72-6. PubMed ID: 11760562
    [No Abstract]   [Full Text] [Related]  

  • 18. Alpha erythropoietin in the management of anaemia of prematurity: a report of three cases in Nigeria.
    Awogu AU; Abohweyere AE
    Niger Postgrad Med J; 2006 Dec; 13(4):361-5. PubMed ID: 17203112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human erythropoietin therapy in the surgical setting and applications in oncology.
    Goodnough LT
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):98-102. PubMed ID: 1928088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controversies in the management of the anemia of prematurity using single-donor red blood cell transfusions and/or recombinant human erythropoietin.
    Strauss RG
    Transfus Med Rev; 2006 Jan; 20(1):34-44. PubMed ID: 16373186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.